AGINKO Research is the premiere CRO for preclinical work in osteoarticular pathologies. We offer a wide range of contract research services to support Drug and Medical Device established companies as well as start-ups and academia. From industry standard protocols to customized research design, our animal models and assays, both on an in vivo or in vitro basis, provide key tools for compound discovery and product development.
Given our expertise, know-how, and network in the field of osteoarticular pathologies, AGINKO today also offers a full range of histology services for your preclinical and clinical trials as well as general consulting services (e.g., regulatory, strategy, financing) devoted to osteoarticular pathologies.
BioCentrum's mission is to create a platform for our clients and partners in order to help them translate innovative discoveries into preclinical candidates with improved chances to become marketed in the least amount of time possible. Our offer is a range of in vitro and in vivo assays that are created toward incorporating preclinical information into your pipeline.
Our company is recognized for excellence in providing ISO 9001monoclonal and polyclonal antibodies, antigens, enzymes, and purified proteins to the research and medical diagnostic marketplace. Nearly all of our products are validated for usage in quantitative sandwich immunoassay and qualitative rapid testing.
We offer immunological reagents worldwide for diagnostics & research in the following disciplines:
We are happy to inform you that Advanced ImmunoChemical is now offering a set of antibodies produced In vitro. In addition, some of our current antibodies are now available both as In vivo- and In vitro-produced products.
Monoclonal antibodies and mammalian antigens for detecting infectious diseases, cardiac biomarkers, and hormones.
Broad selection antibodies and inactivated viral antigens to detect Influenza A and B in clinical samples.
Monoclonal antibodies for the detection of biological threats and dangerous pathogens.
Biomarkers for cardiovascular disease prevention, risk assessment, and diagnostics.
Customers Include: Princeton University, Duke University School of Medicine, Columbia University Medical Center, CDC, National Institutes of Health, Naval Health Research Center, Los Alamos National Laboratory, US Army Medical Research Institute of Infectious Diseases, Sandia National Laboratories, Stanfored Medicine, NIST, NIMH, Harvard Medical School, Yale University School of Medicine, John Hopkins School of Medicine, Lawrence Livermore National Laboratory, and many more!
Advanced ImmunoChemical is a WBENC-certified woman-owned small business, since 1986.
Altogen Labs is a biology CRO company providing GLP preclinical research services, tox studies for IND applications, RNAi and gene silencing services, xenograft testing services (100+ tumorigenic cell lines), in vivo siRNA delivery and biodistribution, development of stable cell lines, and many more.
Altogen Labs is a GLP compliant laboratory that provides preclinical research and biotechnology contract research services (CRO) to pharma, biotechnology companies, universities, and cancer research centers worldwide. Our services include pharmacology and toxicology assays (IC50), cell banking, generation of stable cell lines, RNAi gene silencing and other in vitro services. Altogen Labs provides following in vivo services for efficacy studies in the drug discovery phase: rodent xenograft models, teratoma formation and analysis services, cancer disease animal models, in vivo siRNA delivery and tissue targeting, pharmacokinetics (PK) and pharmacodynamics (PD) services, immune response and biomarker analysis.
Altogen Labs recently developed an `active bioremediation` process based on an approach using the most potent oil-degrading bacteria found at multiple oil spill sites in Texas. This technology allows remediation of large amounts of hydrocarbon-contaminated liquids or soil. The genomes of both microorganisms were recently sequenced, which revealed that both strains were previously unreported in the literature. Altogen Labs filed bioremeddiation patent application in 6/2012.
We provide world-class analytical instruments and services for validating, selecting and optimizing drug candidates. For our track record of 75+ analyzed candidates we have so far improved the overall clinical trial success rate by more than 4x. By accurately classifying candidates prior to clinical trials, we allow pharmaceutical companies to focus on the most promising candidates, increasing their efficiency and profitability.
Attana was founded with the vision of in vitro characterization of molecular interactions, mimicking in vivo conditions. We have developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays. We are also developing the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool, for e.g. SARS-CoV-2 testing and immunity profiling.
To learn more about our latest services and products, please visit www.attana.com or contact email@example.com.